474 related articles for article (PubMed ID: 33538666)
1.
Syed AA; Reza MI; Singh P; Thombre GK; Gayen JR
Curr Drug Metab; 2021; 22(7):561-571. PubMed ID: 33538666
[TBL] [Abstract][Full Text] [Related]
2. Withania somnifera (L.) Dunal - Modern perspectives of an ancient Rasayana from Ayurveda.
Mukherjee PK; Banerjee S; Biswas S; Das B; Kar A; Katiyar CK
J Ethnopharmacol; 2021 Jan; 264():113157. PubMed ID: 32783987
[TBL] [Abstract][Full Text] [Related]
3. Neurodegenerative diseases and Withania somnifera (L.): An update.
Dar NJ; MuzamilAhmad
J Ethnopharmacol; 2020 Jun; 256():112769. PubMed ID: 32240781
[TBL] [Abstract][Full Text] [Related]
4. Withania somnifera: an Indian ginseng.
Kulkarni SK; Dhir A
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1093-105. PubMed ID: 17959291
[TBL] [Abstract][Full Text] [Related]
5. Review on anticancerous therapeutic potential of Withania somnifera (L.) Dunal.
Singh N; Yadav SS; Rao AS; Nandal A; Kumar S; Ganaie SA; Narasihman B
J Ethnopharmacol; 2021 Apr; 270():113704. PubMed ID: 33359918
[TBL] [Abstract][Full Text] [Related]
6. Metabolomics of Withania somnifera (L.) Dunal: Advances and applications.
Tetali SD; Acharya S; Ankari AB; Nanakram V; Raghavendra AS
J Ethnopharmacol; 2021 Mar; 267():113469. PubMed ID: 33075439
[TBL] [Abstract][Full Text] [Related]
7. In vitro protective effects of Withania somnifera (L.) dunal root extract against hydrogen peroxide and β-amyloid(1-42)-induced cytotoxicity in differentiated PC12 cells.
Kumar S; Seal CJ; Howes MJ; Kite GC; Okello EJ
Phytother Res; 2010 Oct; 24(10):1567-74. PubMed ID: 20680931
[TBL] [Abstract][Full Text] [Related]
8. Ashwagandha in brain disorders: A review of recent developments.
Zahiruddin S; Basist P; Parveen A; Parveen R; Khan W; Gaurav ; Ahmad S
J Ethnopharmacol; 2020 Jul; 257():112876. PubMed ID: 32305638
[TBL] [Abstract][Full Text] [Related]
9. Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: ashwagandha.
Ven Murthy MR; Ranjekar PK; Ramassamy C; Deshpande M
Cent Nerv Syst Agents Med Chem; 2010 Sep; 10(3):238-46. PubMed ID: 20528765
[TBL] [Abstract][Full Text] [Related]
10. Withania somnifera (L.) Dunal (Ashwagandha): A comprehensive review on ethnopharmacology, pharmacotherapeutics, biomedicinal and toxicological aspects.
Paul S; Chakraborty S; Anand U; Dey S; Nandy S; Ghorai M; Saha SC; Patil MT; Kandimalla R; Proćków J; Dey A
Biomed Pharmacother; 2021 Nov; 143():112175. PubMed ID: 34649336
[TBL] [Abstract][Full Text] [Related]
11. Withania somnifera (Ashwagandha) in neurobehavioural disorders induced by brain oxidative stress in rodents: a systematic review and meta-analysis.
Durg S; Dhadde SB; Vandal R; Shivakumar BS; Charan CS
J Pharm Pharmacol; 2015 Jul; 67(7):879-99. PubMed ID: 25828061
[TBL] [Abstract][Full Text] [Related]
12. Ashwagandha: Advances in plant biotechnological approaches for propagation and production of bioactive compounds.
Namdeo AG; Ingawale DK
J Ethnopharmacol; 2021 May; 271():113709. PubMed ID: 33346029
[TBL] [Abstract][Full Text] [Related]
13. Keeping abreast about ashwagandha in breast cancer.
Vashi R; Patel BM; Goyal RK
J Ethnopharmacol; 2021 Apr; 269():113759. PubMed ID: 33359916
[TBL] [Abstract][Full Text] [Related]
14. Network ethnopharmacological evaluation of the immunomodulatory activity of Withania somnifera.
Chandran U; Patwardhan B
J Ethnopharmacol; 2017 Feb; 197():250-256. PubMed ID: 27487266
[TBL] [Abstract][Full Text] [Related]
15.
Bhat JA; Akther T; Najar RA; Rasool F; Hamid A
Front Pharmacol; 2022; 13():1029123. PubMed ID: 36578541
[TBL] [Abstract][Full Text] [Related]
16. Effects of Ashwagandha (roots of Withania somnifera) on neurodegenerative diseases.
Kuboyama T; Tohda C; Komatsu K
Biol Pharm Bull; 2014; 37(6):892-7. PubMed ID: 24882401
[TBL] [Abstract][Full Text] [Related]
17.
Lerose V; Ponticelli M; Benedetto N; Carlucci V; Lela L; Tzvetkov NT; Milella L
Plants (Basel); 2024 Mar; 13(6):. PubMed ID: 38592845
[No Abstract] [Full Text] [Related]
18. A systematic review of the clinical use of Withania somnifera (Ashwagandha) to ameliorate cognitive dysfunction.
Ng QX; Loke W; Foo NX; Tan WJ; Chan HW; Lim DY; Yeo WS
Phytother Res; 2020 Mar; 34(3):583-590. PubMed ID: 31742775
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic overview of Withania somnifera, the Indian Ginseng.
Dar NJ; Hamid A; Ahmad M
Cell Mol Life Sci; 2015 Dec; 72(23):4445-60. PubMed ID: 26306935
[TBL] [Abstract][Full Text] [Related]
20. Modulation of GPCR receptors common to gut inflammatory diseases and neuronal disorders, Alzheimer's and Parkinson's diseases as druggable targets through
Shukla R; Pahal S; Gupta A; Choudhary P; Misra K; Singh S
J Biomol Struct Dyn; 2023 Jul; 41(10):4485-4503. PubMed ID: 35491707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
